OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients
The purpose of this study is to evaluate the long-term safety and efficacy of OraVescent fentanyl to treat breakthrough pain episodes in cancer patients who are already opioid tolerant.
Pain|Cancer
DRUG: OraVescent fentanyl citrate
Tolerability and safety of OraVescent fentanyl when used long-term
Assess the effectiveness of OraVescent fentanyl|Assess the development of incremental tolerance
The objective of this study is to determine the tolerability and safety of OraVescent fentanyl when used long term to relieve breakthrough pain in opioid tolerant cancer patients.